Anti-MSLN CAR-like NK cells, which only exhibited targeted effects, tended to slow tumor growth and disease progression, but their efficacy was inferior to that of anti-MSLN uCAR-like NK cells with penetrating activity (Fig. 6h, i). Here, MSLN is linked to neoplasm.